...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Question on valuing shares from time of spinoff

Does anybody recall how we were instructed to value the shares from the time of spinoff?

My brokerage values them at 66 cents at this time.

 

Thanks...

bfw

Share
New Message
Please login to post a reply